Page last updated: 2024-08-26

methyllycaconitine and n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide

methyllycaconitine has been researched along with n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crooks, PA; Dhawan, GK; Dwoskin, LP; Siripurapu, KB; Smith, AM; Zhang, Z1

Other Studies

1 other study(ies) available for methyllycaconitine and n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide

ArticleYear
The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
    Biochemical pharmacology, 2009, Oct-01, Volume: 78, Issue:7

    Topics: Aconitine; Allosteric Regulation; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Norepinephrine; Picolines; Rats; Rats, Sprague-Dawley; Tritium

2009